Medicines for Europe, member of The PTG, representing manufacturers of generic, biosimilar and value added medicines across Europe, welcomes the proposals to review the EU general pharmaceutical legislation. As the off-patent sector accounting for 70% of medicines dispensed in Europe across 80% of therapeutic areas, we fully share the goals of ensuring that all patients in the EU have timely and equitable access to…
PTG
Polskie Towarzystwo Gospodarcze
Industry association · Poland
not in the EU Transparency RegisterThis organization files on consultations without a register number, so its record here is built from its filings alone. Register facts (staff, costs, accreditations) are not available for it.
2
positions filed
in the 665 files tracked
1
legislative file
of 665 tracked
2
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,800 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Track Polskie in PolicySpeak: request access →
Work at Polskie Towarzystwo Gospodarcze? so we know who speaks for it.
Their record over time
Polskie Towarzystwo Gospodarcze filed 2 positions on 6 Nov 2023, across 1 of the 665 legislative files tracked here, attaching a full position paper 2 times.
What they argued
Opinion on behalf of a member of the Polish Economic Society - Medicines for Poland. Medicines for Europe, representing manufacturers of generic, biosimilar and value added medicines across Europe, welcomes the proposals to review the EU general pharmaceutical legislation.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Polskie Towarzystwo Gospodarcze next to another organization. Same files, same register facts, side by side. Compare →
Is this your organization?
Everything on this page comes from Polskie Towarzystwo Gospodarcze’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.